Heart Disease Trial, Recruiting NCT06311461 Sponsor: University of California, Los Angeles Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06311461
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with stable angina or a chest pain condition for at least 1 month (this includes pain, pressure, or discomfort in the chest or other parts of the upper body).
  • People who have been receiving medical treatment for this condition for at least 1 month.
  • People who experience these symptoms at least once per week.
  • People who can speak and read English.
  • People who are at least 21 years of age.

Who may not be able to join:

  • People who are pregnant, as some of the acupuncture points used in this trial are not considered safe during pregnancy.
  • People who have physical or mental limitations that would prevent them from giving informed consent or completing the study tasks.
  • People who are currently using steroid medications or prescription pain medications.
  • People who are currently receiving biofeedback therapy, professional massage, or acupuncture treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Holli A. DeVon, PhD, University of California, Los Angeles

Phone: 3109107283

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pain Now; Worst Pain; Least Pain; Acute Coronary Syndrome like symptoms (ACS Symptom Checklist); Anginal Pain (Seattle Angina Questionnaire-7); Number of Angina Attacks (From American Heart Association Angina Log); Symptom Triggers (From American Heart Association Angina Log); Pain from Angina Attack (From American Heart Association Angina Log); Length of Angina Attack (American Heart Association Angina Log); Self-treatment for Symptoms (From American Heart Association Angina Log)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov